Zevra Therapeutics (ZVRA) Non-Current Debt (2014 - 2025)
Zevra Therapeutics' Non-Current Debt was $61.93 million in Q4 2025, up 4.1% from $59.5 million a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Non-Current Debt (2014 - 2025) Analysis & Trends
From Q4 2014 onward, Zevra Therapeutics has reported Non-Current Debt for 24 quarters.
- Non-Current Debt shows a five-year compound annual growth rate of 175.4% (FY2020 to FY2025).
- In earlier years, Non-Current Debt was $59.5 million in FY2024, $5.07 million in FY2023 (-60.4%) and $12.8 million in FY2022.
- The Q4 2025 figure marks the highest quarterly Non-Current Debt in data going back to Q4 2014.
- Compared with a year earlier, Non-Current Debt has increased for four straight quarters, with growth averaging 96.4% over the last seven quarters.
- The best year-over-year quarter for Non-Current Debt over five years was Q2 2024 (growth of 359.0%); the worst was Q4 2023 (a decline of 60.4%).
- Per Business Quant data, ZVRA's Non-Current Debt in the three quarters before Q4 2025 was $61.31 million (Q3 2025), $60.69 million (Q2 2025) and $60.09 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Zevra Therapeutics | 672.94 Mn | -139.77 Mn | 38.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 61.93 Mn |
| Sep 30, 2025 | 61.31 Mn |
| Jun 30, 2025 | 60.69 Mn |
| Mar 31, 2025 | 60.09 Mn |
| Dec 31, 2024 | 59.50 Mn |
| Sep 30, 2024 | 58.90 Mn |
| Jun 30, 2024 | 58.33 Mn |
| Mar 31, 2024 | 37.94 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Sep 30, 2023 | 38.80 Mn |
| Jun 30, 2023 | 12.71 Mn |
| Mar 31, 2023 | 12.91 Mn |
| Dec 31, 2022 | 12.80 Mn |
| Sep 30, 2022 | 12.80 Mn |
| Jun 30, 2022 | 12.80 Mn |
| Mar 31, 2021 | 98,000.00 |
| Dec 31, 2020 | 391,000.00 |
| Sep 30, 2020 | 781,000.00 |
| Jun 30, 2020 | 781,000.00 |
| Dec 31, 2015 | 11.12 Mn |
API Access
Zevra Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();